A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/663 (2006.01) A61K 9/00 (2006.01) A61K 31/4535 (2006.01) A61P 19/08 (2006.01) A61P 19/10 (2006.01)
Patent
CA 2555406
Provided are methods of treating bone disease including, but not limited to, osteoporosis, metastatic bone disease, or Paget~s disease, by administering a combination of raloxifene and alendronate in a manner that mitigates the formation of ulcerative adverse events.
Cette invention concerne des methodes de traitement d'une maladie osseuse telle que l'ostéoporose, la maladie osseuse métastatique ou la maladie de Paget, lesquelles méthodes consistent à administrer une combinaison de raloxifène et d'alendronate d'une façon qui atténue la formation d'événements indésirables ulcératifs.
Flashner-Barak Moshe
Lerner Itzhak E.
Heenan Blaikie Llp
Teva Pharmaceutical Industries Ltd.
LandOfFree
Improved therapy using a combination of raloxifene and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Improved therapy using a combination of raloxifene and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved therapy using a combination of raloxifene and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2071109